Policy & Medicine January 16, 2025
Thomas Sullivan

In the final days of the Biden administration the Drug Enforcement Administration (DEA) has issued new regulations on who can prescribe controlled substances. This is the agencies third attempt at a proposed rule on the topic.

These updates from the DEA have sparked a vigorous debate among stakeholders, highlighting the balance between innovation in healthcare services and the stringent requirements to prevent substance misuse.

DEA’s Proposed Rule for Telehealth Controlled Substance Prescribing

The DEA recently proposed a rule aimed at regulating the telehealth prescribing of controlled substances. This rule is specifically designed to address the complexities of prescribing practices that have evolved significantly with the rise of telehealth services. The proposed rule, outlined in the Federal Register,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Govt Agencies, Patient / Consumer, Provider, Technology, Telehealth
Remote Patient Monitoring: The Standard of Care has Changed
Three ways the Trump administration could reinvest in rural America's future, starting with health care
Using AI to reimagine telehealth with a fair, effective billing model
Can Telemedicine Solve the Rural Healthcare Crisis?
Global Increase in Remote Patient Monitoring as Telehealth Expands

Share This Article